Search results for "Highlights"
HbA1c level may predict cardiovascular events in high-risk patients with diabetes
Glycemic control as measured by HbA1c level remains strongly and independently associated with cardiovascular outcomes in high-risk patients with diabetes on statin therapy.
https://diabetes.acponline.org/archives/2020/01/10/3.htm
10 Jan 2020
Study finds ‘marked improvements’ in diabetes management from 1999 to 2016
While the proportion of U.S. adults with diabetes who attained glycemic, blood pressure, and lipid control increased during the study period, there was a lack of progress related to dietary guidelines.
https://diabetes.acponline.org/archives/2020/01/10/2.htm
10 Jan 2020
Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes
A systematic review and meta-analysis of seven studies found that intermittent fasting induced a greater decrease in body weight compared to regular diet but was not associated with any greater reduction in HbA1c levels.
https://diabetes.acponline.org/archives/2021/01/08/1.htm
8 Jan 2021
Roux-en-Y gastric bypass associated with better long-term diabetes outcomes than sleeve gastrectomy
While both procedures were associated with high rates of type 2 diabetes remission, the rate of remission five years after surgery was about 10% higher in patients who had gastric bypass than in those who had sleeve gastrectomy.
https://diabetes.acponline.org/archives/2020/03/13/3.htm
13 Mar 2020
HbA1c testing in barbershops identified black men with undiagnosed diabetes
About one-third of men approached in barbershops owned by black individuals were willing to be screened for diabetes, and 9% of them had undiagnosed diabetes while 28% had prediabetes.
https://diabetes.acponline.org/archives/2020/02/14/2.htm
14 Feb 2020
Oral semaglutide led to greater reductions in HbA1c, body weight than sitagliptin
The industry-funded PIONEER 3 trial randomized adults whose type 2 diabetes was uncontrolled with metformin, with or without sulfonylurea, to receive either oral sitagliptin (100 mg/d) or oral semaglutide (3, 7, or 14 mg/d).
https://diabetes.acponline.org/archives/2019/04/05/2.htm
5 Apr 2019
Diabetes apps require additional validation, education on their use, consensus report finds
Clinicians should be aware of the strengths and weaknesses of diabetes apps and be able to advise patients on their use, according to the European Association for the Study of Diabetes and the American Diabetes Association.
https://diabetes.acponline.org/archives/2019/12/13/3.htm
13 Dec 2019
Different diabetes phenotypes associated with varying prevalence of complications
Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.
https://diabetes.acponline.org/archives/2019/08/09/3.htm
9 Aug 2019
Metabolic surgery associated with lower risk for MACE in obese adults with type 2 diabetes
Patients with diabetes and obesity who had metabolic surgery were matched in a 1:5 ratio to those who received usual care, with incidence of a major cardiovascular event (MACE) as the primary outcome.
https://diabetes.acponline.org/archives/2019/09/13/3.htm
13 Sep 2019
CGM improved glycemic control in type 1 diabetes with or without pump
Real-time continuous glucose monitoring (CGM), with either an insulin pump or multiple daily injections, was associated with sustained improvements in HbA1c levels compared to self-monitoring of blood glucose, according to a small randomized trial.
https://diabetes.acponline.org/archives/2019/10/11/2.htm
11 Oct 2019